Daria Mochly-Rosen Selected Research

Protein Kinase C-epsilon

10/2005	PKC-{epsilon}-dependent survival signals in diabetic hearts.
8/2005	Ethanol withdrawal-associated allodynia and hyperalgesia: age-dependent regulation by protein kinase C epsilon and gamma isoenzymes.
1/2004	Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C epsilon.
10/2002	Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta.
6/2002	Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts.
5/2002	Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daria Mochly-Rosen Research Topics

Disease

29	Ischemia 01/2016 - 06/2002
21	Myocardial Infarction 02/2022 - 08/2006
18	Neoplasms (Cancer) 10/2022 - 05/2002
16	Reperfusion Injury 02/2022 - 08/2003
15	Heart Failure 10/2019 - 10/2002
11	Inflammation (Inflammations) 01/2022 - 10/2007
11	Infarction (Infarctions) 10/2013 - 11/2003
10	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 11/2011
8	Pain (Aches) 11/2021 - 05/2004
6	Glucosephosphate Dehydrogenase Deficiency 01/2022 - 06/2016
6	Hypertension (High Blood Pressure) 07/2012 - 10/2002
6	Cardiomegaly (Heart Hypertrophy) 10/2011 - 10/2002
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2012
5	Flushing 01/2022 - 02/2010
5	Huntington Disease (Huntington's Disease) 01/2018 - 12/2013
5	Stroke (Strokes) 01/2017 - 07/2003
4	Fibrosis (Cirrhosis) 03/2021 - 01/2008
4	Heart Diseases (Heart Disease) 03/2015 - 01/2008
4	Hypertrophy 10/2011 - 10/2002
4	Brain Ischemia (Cerebral Ischemia) 12/2005 - 07/2003
3	COVID-19 01/2022 - 01/2021
3	Hemolytic Anemia 01/2022 - 10/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 09/2013 - 02/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 05/2005 - 01/2004
2	Carcinogenesis 02/2022 - 05/2002
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2021
2	Atrial Fibrillation 01/2021 - 12/2016
2	Brain Diseases (Brain Disorder) 01/2020 - 01/2011
2	Sepsis (Septicemia) 01/2020 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 12/2016
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 01/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2018 - 08/2013
2	Xerostomia 12/2018 - 08/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 08/2017
2	Cardiotoxicity 01/2018 - 11/2011
2	Diabetes Complications 01/2018 - 12/2012
2	Parkinson Disease (Parkinson's Disease) 12/2016 - 02/2013
2	Heart Arrest (Cardiac Arrest) 01/2016 - 06/2005
2	Brain Injuries (Brain Injury) 06/2013 - 07/2003
2	Angina Pectoris 01/2012 - 11/2011
2	Prostatic Neoplasms (Prostate Cancer) 06/2011 - 08/2008
2	Atherosclerosis 01/2010 - 01/2008
2	Hyperglycemia 01/2009 - 10/2005
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2008 - 10/2002

Drug/Important Bio-Agent (IBA)

23	Protein Kinase CIBA 10/2011 - 06/2002
20	AldehydesIBA 10/2022 - 09/2008
20	Proteins (Proteins, Gene)FDA Link 03/2021 - 05/2002
19	Peptides (Polypeptides)IBA 02/2022 - 08/2003
17	IsoenzymesIBA 09/2013 - 05/2002
16	Aldehyde DehydrogenaseIBA 12/2019 - 02/2009
12	EnzymesIBA 10/2022 - 07/2005
9	Phosphotransferases (Kinase)IBA 02/2022 - 11/2003
7	Ethanol (Ethyl Alcohol)IBA 12/2019 - 08/2005
6	Pharmaceutical PreparationsIBA 10/2022 - 02/2008
6	delta proteinIBA 02/2022 - 11/2003
6	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2022 - 06/2016
6	Protein Kinases (Protein Kinase)IBA 06/2013 - 11/2004
6	Protein Kinase C-epsilonIBA 10/2005 - 05/2002
5	Amino Acids FDA Link 02/2022 - 08/2006
5	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 11/2021 - 04/2010
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 07/2004
5	SaltsIBA 12/2008 - 10/2002
4	Oxidoreductases (Dehydrogenase)IBA 10/2022 - 07/2005
4	AcetaldehydeIBA 02/2022 - 02/2010
4	Oxygen (Dioxygen)IBA 06/2005 - 12/2003
3	Protein Isoforms (Isoforms)IBA 10/2022 - 06/2002
3	Protein Kinase C-deltaIBA 02/2022 - 08/2004
3	VaccinesIBA 01/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2008
3	Adenosine Triphosphate (ATP)IBA 12/2018 - 10/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 02/2013
3	polyglutamineIBA 11/2016 - 01/2014
3	Huntingtin ProteinIBA 11/2016 - 12/2013
3	Neuroprotective AgentsIBA 01/2015 - 12/2005
3	Mitochondrial Aldehyde DehydrogenaseIBA 09/2014 - 10/2010
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2012 - 01/2008
2	IgYIBA 01/2022 - 01/2021
2	LipopolysaccharidesIBA 01/2021 - 01/2020
2	Dynamins (Dynamin)IBA 01/2020 - 01/2019
2	BilirubinIBA 10/2018 - 06/2016
2	Cisplatin (Platino)FDA LinkGeneric 08/2017 - 05/2017
2	Biological ProductsIBA 12/2016 - 06/2011
2	CalciumIBA 01/2016 - 01/2016
2	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 10/2015 - 06/2013
2	Therapeutic UsesIBA 01/2015 - 12/2008
2	Analgesics (Analgesic Drugs)IBA 08/2014 - 01/2014
2	Opioid Analgesics (Opioids)IBA 01/2014 - 07/2004
2	BradykininIBA 09/2013 - 04/2009
2	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2012 - 11/2011
2	Formaldehyde (Formol)FDA Link 08/2011 - 05/2004
2	tat Gene Products (tat Protein)IBA 10/2010 - 08/2003
2	Creatine Kinase (Creatine Phosphokinase)IBA 02/2009 - 08/2003
2	Receptors for Activated C KinaseIBA 01/2009 - 10/2005
2	dimemorfan (AT 17)IBA 06/2008 - 10/2002
2	Cytochromes c (Cytochrome c)IBA 08/2007 - 06/2005

Therapy/Procedure

10	Therapeutics 10/2022 - 01/2007
3	Radiotherapy 12/2018 - 07/2012
2	Intraperitoneal Injections 02/2009 - 05/2007
2	Heart Transplantation (Grafting, Heart) 10/2007 - 09/2004